17β-estradiol decreases vascular tone in cerebral arteries by shifting COX-dependent vasoconstriction to vasodilation

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 285, Issue 1 54-1, 2003, Pages

  Ospina, Jose A ^a   Duckles, Sue P ^a   Krause, Diana N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cyclooxygenase; Prostacyclin; Prostaglandin endoperoxide

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; 7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; ARACHIDONIC ACID; CYCLOOXYGENASE 1; ESTRADIOL; FUREGRELATE; INDOMETACIN; PROSTACYCLIN; PROSTAGLANDIN ENDOPEROXIDE; PROSTAGLANDIN H2; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; THROMBOXANE RECEPTOR; THROMBOXANE SYNTHASE; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; CYTOCHROME P450; ISOENZYME; ISOMERASE; MEMBRANE PROTEIN; PROSTACYCLIN SYNTHASE; PROSTAGLANDIN; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; PTGS1 PROTEIN, RAT; VASOCONSTRICTOR AGENT;

ADOLESCENT; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DIAMETER; ARTERY DILATATION; ARTERY RESISTANCE; ARTERY TONE; ARTICLE; BRAIN ARTERY; BRAIN BLOOD FLOW; CONTROLLED STUDY; ENZYME INHIBITION; ESTROGEN ACTIVITY; FEMALE; MIDDLE CEREBRAL ARTERY; NONHUMAN; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM; ANIMAL; BIOSYNTHESIS; BODY WEIGHT; DRUG EFFECT; FISCHER 344 RAT; METABOLISM; MUSCLE CONTRACTION; MUSCLE TONE; ORGAN SIZE; PHYSIOLOGY; PRESSURE; UTERUS; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; ARACHIDONIC ACID; BODY WEIGHT; CEREBRAL ARTERIES; CYCLOOXYGENASE 1; CYTOCHROME P-450 ENZYME SYSTEM; ESTRADIOL; FEMALE; INTRAMOLECULAR OXIDOREDUCTASES; ISOENZYMES; MEMBRANE PROTEINS; MUSCLE CONTRACTION; MUSCLE TONUS; MUSCLE, SMOOTH, VASCULAR; ORGAN SIZE; PRESSURE; PROSTAGLANDIN ANTAGONISTS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; RATS; RATS, INBRED F344; UTERUS; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 0038677091     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00018.2003     Document Type: Article

References (50)

1. Boyle CA. Management of menstrual migraine. Neurology 53: S14-S18, 1999.
2. Brackley KJ, Ramsay MM, Pipkin FB, and Rubin PC. The effect of the menstrual cycle on human cerebral blood flow: studies using Doppler ultrasound. Ultrasound Obstet Gynecol 14: 52-57, 1999.
3. Busija DW. Prostaglandins and other eicosanoids. In: Cerebral Blood Flow and Metabolism (2nd ed.), edited by Edvinsson L and Krause DN. Philadelphia, PA: Lippincott, Williams & Wilkins, 2002, p. 325-338.
4. Davidge ST. Prostaglandin H synthase and vascular function. Circ Res 89: 650-660, 2001.
5. Davidge ST and Zhang Y. Estrogen replacement suppresses a prostaglandin H synthase-dependent vasoconstrictor in rat mesenteric arteries. Circ Res 83: 388-395, 1998.
6. 2 reactivity in stroke-age normal controls. Neurology 33: 391-399, 1983.
7. Diomedi M, Cupini LM, Rizzato B, Ferrante F, Giacomini P, and Silvestrini M. Influence of physiologic oscillation of estrogens on cerebral hemodynamics. J Neurol Sci 185: 49-53, 2001.
8. Faraci FM. Role of endothelium-derived relaxing factor in cerebral circulation: large arteries versus microcirculation. Am J Physiol Heart Circ Physiol 261: H1038-H1042, 1991.
9. Finucane FF, Madans JH, Bush TL, Wolf PH, and Kleinman JC. Decreased risk of stroke among postmenopausal hormone users. Results from a national cohort. Arch Intern Med 153: 73-79, 1993.
10. Geary GG, Krause DN, and Duckles SP. Estrogen reduces mouse cerebral artery tone through endothelial NOS- and cyclooxygenase-dependent mechanisms. Am J Physiol Heart Circ Physiol 279: H511-H519, 2000.
11. Geary GG, Krause DN, and Duckles SP. Estrogen reduces myogenic tone through a nitric oxide-dependent mechanism in rat cerebral arteries. Am J Physiol Heart Circ Physiol 275: H292-H300, 1998.
12. Geary GG, Krause DN, and Duckles SP. Gonadal hormones affect diameter of male rat cerebral arteries through endothelium-dependent mechanisms. Am J Physiol Heart Circ Physiol 279: H610-H618, 2000.
13. Geary GG, McNeill AM, Ospina JA, Krause DN, Korach KS, and Duckles SP. Genome and hormone: gender differences in physiology selected contribution. Cerebrovascular NOS and cyclooxygenase are unaffected by estrogen in mice lacking estrogen receptor-α. J Appl Physiol 91: 2391-2399, 2001.
14. Habermehl DA, Janowiak MA, Vagnoni KE, Bird IM, and Magness RR. Endothelial vasodilator production by uterine and systemic arteries. IV Cyclooxygenase isoform expression during the ovarian cycle and pregnancy in sheep. Biol Reprod 62: 781-788, 2000.
15. Henderson BE, Paganini-Hill A, and Ross RK. Decreased mortality in users of estrogen replacement therapy. Arch Intern Med 151: 75-78, 1991.
16. 2α-isoprostane production in cultured human endothelial cells. Am J Physiol Heart Circ Physiol 283: H2644-H2649, 2002.
17. Hoffman SW, Moore S, and Ellis EF. Isoprostanes: free radical-generated prostaglandins with constrictor effects on cerebral arterioles. Stroke 28: 844-849, 1997.
18. 2 in arterioles of hypertensive rats. Hypertension 35: 925-930, 2000.
19. Hurn PD and Macrae IM. Estrogen as a neuroprotectant in stroke. J Cereb Blood Flow Metab 20: 631-652, 2000.
20. Iadecola C, Sugimoto K, Niwa K, Kazama K, and Ross ME. Increased susceptibility to ischemic brain injury in cyclooxygenase-1 deficient mice. J Cereb Blood Flow Metab 21: 1436-1441, 2001.
21. Jun SS, Chen Z, Pace MC, and Shaul PW. Estrogen upregulates cyclooxygenase-1 gene expression in ovine fetal pulmonary artery endothelium. J Clin Invest 102: 176-183, 1998.
22. 2 reactivity. J Neurol Sci 162: 127-132, 1999.
23. Lin H, Lin TN, Cheung WM, Nian GM, Tseng PH, Chen SF, Chen JJ, Shyue SK, Liou JY, Wu CW, and Wu KK. Cyclooxygenase-1 and bicistronic cyclooxygenase-1/prostacyclin synthase gene transfer protect against ischemic cerebral infarction. Circulation 105: 1962-1969, 2002.
24. Maki PM and Resnick SM. Effects of estrogen on patterns of brain activity at rest and during cognitive activity: a review of neuroimaging studies. Neuroimage 14: 789-801, 2001.
25. McNeill AM, Kim N, Duckles SP, and Krause DN. Chronic estrogen treatment increases levels of endothelial nitric oxide synthase protein in rat cerebral microvessels. Stroke 30: 2186-2190, 1999.
26. McNeill AM, Zhang C, Stanczyk FZ, Duckles SP, and Krause DN. Estrogen increases endothelial nitric oxide synthase via estrogen receptors in rat cerebral blood vessels: effect preserved after concurrent treatment with medroxyprogesterone acetate or progesterone. Stroke 33: 1685-1691, 2002.
27. Meyer MC, Cummings K, and Osol G. Estrogen replacement attenuates resistance artery adrenergic sensitivity via endothelial dilators. Am J Physiol Heart Circ Physiol 272: H2264-H2270, 1997.
28. Nitter WH, Johnsen LF, and Eriksen M. Acute effects of indomethacin on cerebral blood flow. Pharmacology 51: 48-55, 1995.
29. Niwa K, Haensel C, Ross ME, and Iadecola C. Cyclooxygenase-1 participates in selected vasodilator responses of the cerebral circulation. Circ Res 88: 600-608, 2001.
30. Ohkura T, Teshima Y, Isse K, Matsuda H, Inoue T, Sakai Y, Iwasake N, and Yaoi Y. Estrogen increases cerebral and cerebellar blood flows in post-menopausal women. Menopause 2: 13-18, 1995.
31. Ono H, Sasaki Y, Bamba E, Seki J, Giddings JC, and Yamamoto J. Cerebral thrombosis and microcirculation of the rat during the oestrous cycle and after ovariectomy. Clin Exp Pharmacol Physiol 29: 73-78, 2002.
32. Ospina JA, Krause DN, and Duckles SP. 17β-Estradiol increases rat cerebrovascular prostacyclin synthesis by elevating cyclooxygenase-1 and prostacyclin synthase. Stroke 33: 600-605, 2002.
33. Petroni A, Bertazzo A, Sarti S, and Galli C. Accumulation of arachidonic acid cyclo- and lipoxygenase products in rat brain during ischemia and reperfusion: effects of treatment with GM1-lactone. J Neurochem 53: 747-752, 1989.
34. Quintana A, Raczka E, Giralt MT, and Quintana MA. Effect of aspirin and indomethacin on cerebral circulation in the conscious rat: evidence for a physiological role of endogenous prostaglandins. Prostaglandins 25: 549-556, 1983.
35. Rodriguez G, Warkentin S, Risberg J, and Rosadini G. Sex differences in regional cerebral blood flow. J Cereb Blood Flow Metab 8: 783-789, 1988.
36. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SAA, Howard BV, Johnson KC, Morley-Kotchen J, and Ockene J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288: 321-333, 2002.
37. 2, COX-1, and PGIS protein expression. Biol Reprod 66: 468-474, 2002.
38. Rusa R, Alkayed NJ, Crain BJ, Trystman RJ, Kimes AS, London ED, Klaus JA, and Hurn PD. 17β-Estradiol reduces stroke injury in estrogen-deficient female animals. Stroke 30: 1665-1670, 1999.
39. Shaw TG, Mortel KF, Meyer JS, Rogers RL, Hardenberg J, and Cutaia MM. Cerebral blood flow changes in benign aging and cerebrovascular disease. Neurology 34: 855-862, 1984.
40. Shyue SK, Tsai MJ, Liou JY, Willerson JT, and Wu KK. Selective augmentation of prostacyclin production by combined prostacyclin synthase and cyclooxygenase-1 gene transfer. Circulation 103: 2090-2095, 2001.
41. Smith CJ, Zhang Y, Koboldt CM, Muhammad J, Zweifel BS, Schaffer A, Talley JJ, Masferrer JL, Seibert K, and Isakson PC. Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc Natl Acad Sci USA 95: 13313-13318, 1998.
42. Stewart KG, Zhang Y, and Davidge ST. Estrogen decreases prostaglandin H synthase products from endothelial cells. J Soc Gynecol Investig 6: 322-327, 1999.
43. Sudlow CLM and Warlow CP. Comparable studies of the incidence of stroke and its pathological types. Stroke 28: 491-499, 1997.
44. Watanabe Y, Littleton-Kearney MT, Traystman RJ, and Hurn PD. Estrogen restores postischemic pial microvascular dilation. Am J Physiol Heart Circ Physiol 281: H155-H160, 2001.
45. Whalley ET, Schilling L, and Wahl M. Cerebrovascular effects of prostanoids: in vitro studies in feline middle cerebral and basilar artery. Prostaglandins 38: 625-633, 1989.
46. Wise PM. Estrogens and neuroprotection. Trends Endocrinol Metab 13: 229-230, 2002.
47. Wolf PA. An overview of the epidemiology of stroke. Stroke 2, Suppl 9: 114-116, 1990.
48. Yamada M, Numaguchi Y, Okumura K, Harada M, Naruse K, Matsui H, Ito T, and Hayakawa T. Prostacyclin synthase gene transfer modulates cyclooxygenase-2-derived prostanoid synthesis and inhibits neointimal formation in rat balloon-injured arteries. Arterioscler Thromb Vasc Biol 22: 256-262, 2002.
49. 2 purinoceptors in the cerebrovascular tree of the rat. Am J Physiol Heart Circ Physiol 277: H893-H900, 1999.
50. Zou MH, Leist M, and Ullrich V. Selective nitration of prostacyclin synthase and defective vasorelaxation in atherosclerotic bovine coronary arteries. Am J Pathol 154: 1359-1365, 1999.